<DOC>
	<DOCNO>NCT01002209</DOCNO>
	<brief_summary>This trial aim evaluate hyperbaric oxygen treatment ( HBO ) give postoperatively effective reduce heal time wound complication low extremity bypass surgery patient diabetes . Hypothesis : Postoperative HBO treatment effective reduce complication patient diabetes undergoing peripheral vascular surgery</brief_summary>
	<brief_title>Postoperative Hyperbaric Oxygen Treatments Reduce Complications Diabetic Patients Undergoing Vascular Surgery</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Patients eligible inclusion follow criterion fulfil Informed consent obtain Scheduled low extremity open vascular surgery Diabetes treat insulin oral antidiabetic medicine Age â‰¥ 18 year Contraindications HBO therapy Pregnancy ( woman childbearing potential undergo pregnancy test inclusion ) Patients already HBO treatment Vascular reoperation Creatinine &gt; 250 mmol/L NYHA class IV heart failure severe cardiopulmonary disease desaturation judge incompatible safe HBO/ placebo therapy monoplace chamber Clinically significant chronic obstructive pulmonary disease . Acute sepsis . Malignancy serious medical condition likely patient significantly deteriorate survive within two year follow . Simultaneous previous ( within 30 day prior study entry participation clinical study use experimental drug device . Mental condition make subject unable understand concept risk study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Vascular Surgery</keyword>
	<keyword>Hyperbaric oxygen</keyword>
	<keyword>Surgical complication</keyword>
	<keyword>Wound complication</keyword>
	<keyword>Randomized</keyword>
	<keyword>Controlled</keyword>
</DOC>